文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期，新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

The evolving role of GLP-1 agonists in ischemic stroke prevention in diabetic patients.

作者信息

Shankar Aditi, Sharma Aditi, Buch Chirag, Chilton Robert J

机构信息

Division of Cardiology, Department of Medicine, University of Texas Health San Antonio, San Antonio, Texas, USA.

出版信息

Cardiovasc Endocrinol Metab. 2024 Aug 14;13(3):e00308. doi: 10.1097/XCE.0000000000000308. eCollection 2024 Sep.

DOI:10.1097/XCE.0000000000000308
PMID:39148946
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11326472/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af2/11326472/ba97172c0699/xce-13-e00308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af2/11326472/f5d093927869/xce-13-e00308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af2/11326472/ba97172c0699/xce-13-e00308-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af2/11326472/f5d093927869/xce-13-e00308-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3af2/11326472/ba97172c0699/xce-13-e00308-g002.jpg

相似文献

[1]
The evolving role of GLP-1 agonists in ischemic stroke prevention in diabetic patients.

Cardiovasc Endocrinol Metab. 2024-8-14

[2]
GLP-1RAs for Ischemic Stroke Prevention in Patients With Type 2 Diabetes Without Established Atherosclerotic Cardiovascular Disease.

Diabetes Care. 2022-5-1

[3]
GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis.

J Neurol. 2020-7

[4]
GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

J Clin Endocrinol Metab. 2023-6-16

[5]
Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms.

Cardiovasc Diabetol. 2022-11-15

[6]
Risks of stroke, its subtypes and atrial fibrillation associated with glucagon-like peptide 1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: a real-world population-based cohort study in Hong Kong.

Cardiovasc Diabetol. 2023-2-24

[7]
Relationship between Glucagon-like Peptide-1 Receptor Agonists and Cardiovascular Disease in Chronic Respiratory Disease and Diabetes.

Biomedicines. 2024-2-22

[8]
Reducing Ischemic Stroke in Diabetes: The Role of GLP-1 RAs.

J Fam Pract. 2023-7

[9]
Glucagonlike peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors in ischemic strokes with diabetes 2.

Eur J Neurol. 2024-8

[10]
Neuroprotective Mechanisms of Glucagon-Like Peptide-1-Based Therapies in Ischemic Stroke: An Update Based on Preclinical Research.

Front Neurol. 2022-3-15

本文引用的文献

[1]
Risk of stroke and retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: An eight RCTs meta-analysis.

Front Endocrinol (Lausanne). 2022

[2]
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association.

Stroke. 2021-7

[3]
GLP-1 receptor agonists in diabetes for stroke prevention: a systematic review and meta-analysis.

J Neurol. 2020-7

[4]
The glucagon-like peptide-1 receptor agonist reduces inflammation and blood-brain barrier breakdown in an astrocyte-dependent manner in experimental stroke.

J Neuroinflammation. 2019-11-28

[5]
Protection against stroke with glucagon-like peptide 1 receptor agonists: a systematic review and meta-analysis.

Eur J Neurol. 2019-1-30

[6]
Neural mechanisms in remote ischaemic conditioning in the heart and brain: mechanistic and translational aspects.

Basic Res Cardiol. 2018-6-1

[7]
Prevention of cardiovascular events in Asian patients with ischaemic stroke at high risk of cerebral haemorrhage (PICASSO): a multicentre, randomised controlled trial.

Lancet Neurol. 2018-6

[8]
Presynaptic GLP-1 receptors enhance the depolarization-evoked release of glutamate and GABA in the mouse cortex and hippocampus.

Biofactors. 2017-12-19

[9]
Anti-inflammatory Effect of Glucagon Like Peptide-1 Receptor Agonist, Exendin-4, through Modulation of IB1/JIP1 Expression and JNK Signaling in Stroke.

Exp Neurobiol. 2017-8

[10]
Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

N Engl J Med. 2016-9-15

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索